The double-edged sword of growth-stock speculation 2:29 p.m. Nov. 14, 2014 - The Trading Deck
10 S&P 500 companies with the fastest revenue growth 8:28 a.m. Nov. 11, 2014 - Philip van Doorn
Merck, Dendreon miss out on health-care rally 12:39 p.m. Nov. 10, 2014 - Russ Britt
Gilead Sciences rises 2% to top S&P 500 gainers 9:31 a.m. Nov. 10, 2014 - Sue Chang
Visa shares rise after hours on earnings beat 6:50 p.m. Oct. 29, 2014 - Sue Chang
Warren Buffett best wear his trunks as Fed preps to end (pause) the printing 8:34 a.m. Oct. 29, 2014 - Shawn Langlois
Facebook, Gilead shares fall after hours 6:14 p.m. Oct. 28, 2014 - Sue Chang
Updates, advisories and surprises 5:01 p.m. Oct. 28, 2014 - MarketWatch
Sales of Gilead's pricey hepatitis C drug slow 4:26 p.m. Oct. 28, 2014 - MarketWatch.com
Gilead Sciences' stock pulls back from record high close after earnings miss 4:14 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead's stock drops 3.6% in after-hours trade after Q3 results 4:09 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead revises 2014 product sales outlook to $22 bln-$23 bln from $21 bln-$23 bln 4:08 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 Sovaldi sales $2.8 bln vs. $3.48 bln in Q2 4:07 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 sales top FactSet consensus estimate of $5.99 bln 4:07 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 sales $6.04 bln vs. $2.78 bln a year ago 4:07 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 net EPS $1.67 vs. 47 cents a year ago 4:06 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Sciences Q3 adj. EPS $1.84 vs. FactSet consensus $1.92 4:06 p.m. Oct. 28, 2014 - Tomi Kilgore
Two biotech leaders to watch 2:12 p.m. Oct. 28, 2014 - The Trading Deck
Charting a bullish year-end backdrop 12:13 p.m. Oct. 28, 2014 - Michael Ashbaugh
Charting a bullish year-end backdrop 11:53 a.m. Oct. 28, 2014 - Michael Ashbaugh
Biotech Stocks Hit: Stock Market To See New Leaders? 5:22 p.m. Nov. 14, 2014 - Investors Business Daily
Regeneron Pharmaceuticals Offers More Upside Than Gilead Sciences 9:23 a.m. Nov. 14, 2014 - Seeking Alpha
CNBC's Stock Pops & Drops From November 13: King Digital, Alibaba, SanDisk, Gilead Sciences 6:25 a.m. Nov. 14, 2014 - benzinga.com
The Post AASLD Annual Meeting Hepatitis C Landscape 6:15 a.m. Nov. 14, 2014 - Seeking Alpha
If Gilead Has The Ace, Is AbbVie Holding The Big Joker? 2:55 a.m. Nov. 14, 2014 - Seeking Alpha
Gilead Sciences In Correction Mode 12:37 p.m. Nov. 13, 2014 - benzinga.com
Gilead prices debt offering 11:19 a.m. Nov. 13, 2014 - Seeking Alpha
Why Gilead Sciences (GILD) Isn't Done Growing Earnings Yet - Tale of the Tape 8:44 a.m. Nov. 13, 2014 - Zacks.com
4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic 8:38 a.m. Nov. 13, 2014 - 247WallSt.com
Gilead Reports Promising Data on its HCV Drug Harvoni - Analyst Blog 5:00 p.m. Nov. 12, 2014 - Zacks.com
Gilead Sciences Gets Ambushed By The Patent Troll, AbbVie 3:25 p.m. Nov. 12, 2014 - Seeking Alpha
Sub-Optimal 39% Hep C Cure Rate Keeps Merck In Gilead's Rear View 3:13 p.m. Nov. 12, 2014 - Seeking Alpha
Should Investors Buy Twitter Following Its Analyst Day? 3:08 p.m. Nov. 12, 2014 - TheStreet.com
Gilead Sees Large Insider Stock Sale Into Debt Offering 12:38 p.m. Nov. 12, 2014 - 247WallSt.com
3 Stocks Dragging In The Drugs Industry 12:25 p.m. Nov. 12, 2014 - TheStreet.com
Searching The Stars For Quality Stocks 11:43 a.m. Nov. 12, 2014 - Seeking Alpha
Update: These 2 Combinations Will Further Strengthen Gilead's HCV Portfolio 11:17 a.m. Nov. 12, 2014 - Seeking Alpha
Gilead Sciences Releases Impressive Results for Hepatitis C Drug 10:56 a.m. Nov. 12, 2014 - GuruFocus.com
Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bankruptcy - Analyst Blog 8:48 a.m. Nov. 12, 2014 - Zacks.com
Biotech Short Interest Becomes Stock Specific 8:11 a.m. Nov. 12, 2014 - 247WallSt.com
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene 9:10 a.m. Nov. 14, 2014 - PR Newswire - PRF
Reveal Earnings Forecast for BlackBerry, Twitter, Alibaba, Sirius XM, Gilead Sciences, and JD.Com 8:45 a.m. Nov. 14, 2014 - PR Newswire - PRF
Gilead Prices $4 Billion of Senior Unsecured Notes 5:59 p.m. Nov. 12, 2014 - BusinessWire - BZX
Earnings Forecast Recap for Alibaba, Apple, Zynga, Gilead Sciences, Dendreon, and Juniper 8:45 a.m. Nov. 12, 2014 - PR Newswire - PRF
Gilead Announces Phase 2 Data for Investigational All-Oral Regimen of Sofosbuvir Plus GS-5816 for the Treatment of Chronic Hepatitis C 8:02 a.m. Nov. 11, 2014 - BusinessWire - BZX
Gilead Announces Harvoni Study Results in Chronic Hepatitis C Patients with Advanced Liver Disease and Those Who Failed Prior Treatment 8:02 a.m. Nov. 11, 2014 - BusinessWire - BZX
Earnings Forecast Buzz for Alibaba, Genworth Financial, Gilead Sciences, Zynga, Abercrombie & Fitch, and Plug Power 8:45 a.m. Nov. 10, 2014 - PR Newswire - PRF
Medifocus to Be Broadcast on BNN and Fox Business News on November 8th and 9th, 2014 10:56 a.m. Nov. 7, 2014 - Marketwired
Linkage Biosciences Adds to Board Leadership 8:02 a.m. Nov. 7, 2014 - Marketwired
Critical Alerts For Delta Airlines, ConocoPhillips, Qualcomm, Kinder Morgan and Gilead Sciences Released By InvestorsObserver 9:31 a.m. Nov. 6, 2014 - PR Newswire - PRF
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Tenofovir Alafenamide (TAF)-Based Single Tablet Regimen for HIV 8:32 a.m. Nov. 6, 2014 - BusinessWire - BZX
Earnings Forecast Buzz for Alibaba, GT Advanced Technologies, GoPro, Plug Power, Gilead Sciences, and American Realty Capital Properties 8:45 a.m. Nov. 4, 2014 - PR Newswire - PRF
Life-Science New Build Report: 200 New North American Sites in Planning Represent Potential $15 Billion Investment, an Industrial Info News Alert 6:16 a.m. Nov. 4, 2014 - Marketwired
Gilead Sciences Once Again Tops the List of California's Most Honored Companies in Institutional Investor's All-America Executive Team Ranking 6:15 a.m. Nov. 4, 2014 - Marketwired
Earnings Forecast Buzz for American Realty Capital Properties, Alibaba, Petroleo Brasileiro Petrobras SA, Gilead Sciences, RF Micro Devices, and GoPro 8:45 a.m. Oct. 30, 2014 - PR Newswire - PRF
Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly 8:35 a.m. Oct. 29, 2014 - PR Newswire - PRF
Gilead Sciences Announces Third Quarter 2014 Financial Results 4:09 p.m. Oct. 28, 2014 - BusinessWire - BZX
Earnings Forecast Research for DryShips, GoPro, Gilead Sciences, MannKind, GT Advanced Technologies, and Amazon 8:45 a.m. Oct. 27, 2014 - PR Newswire - PRF
Gilead Sciences to Release Third Quarter 2014 Financial Results on Tuesday, October 28, 2014 5:00 p.m. Oct. 21, 2014 - BusinessWire - BZX
Acquisition Updates, Drug Approval, Drug Development Discontinuation, and Contract Update - Research Reports on AbbVie, Gilead, Pfizer, Lilly and Aetna 8:35 a.m. Oct. 20, 2014 - PR Newswire - PRF